prostate disease and erectile dysfunction Flashcards
(49 cards)
the prostate
fibromuscular and glandular organ
tubuloalveolar glands arranged in lobules surrounded by stroke
3 regions of the prostate
TZ - surrounds the urethra, forms benign prostatic hyperplasia and 20% of prostate cancers
PZ - most of the prostate tissue - 70% of cancers
central zone
androgen receptor
expresses in both stromal and epithelial cells
development of prostate is driven by
5a-dihydrotestosterone
DHT
dihydrotestosterone
metabolite of testosterone, converted in the prostate by 5a-reductase type 2
more potent than testosterone due to higher affinity for the androgen receptor
5a-reductase
2 types
type 2 used in the prostate
benign prostatic hyperplasia
nodular overgrowth of both epithelial and fibromuscular components of the periurethral and transition zone of the prostate
androgen dependant and does not predispose to prostate cancer
symptoms of benign prostatic hyperplasia
obstructive - decreased force of urinary stream, hesitancy initiating voiding
irritative symptoms - dysuria. frequency, urgency, nocturia
dynamic obstruction
prostate, prostate capsule and bladder neck have rash a1-adrengeric sympathetic innervation
tension of smooth muscle mediated by these receptors contributes to both obstructive and irritative symptoms
a1- adrenageric blockers
receive rritative and obstructive symptoms
5a-reductase inhibitor
finasteride
dutasteride
drugs used to treat BPH
alpha adrenergic blockers
5a-reductase inhibitors - finasteride and dutasteride
selective a1-adrenergic blockers
prazosin - oldest, short half life, more side effects
terazosn - longer half life
alfuzosin
tamsulosin - selective a1(A)-antagonist, selectivity for the bladder, less postural hypotension
tamsulosin
- selective a1(A)-antagonist, selectivity for the bladder, less postural hypotension
terazosin
anger half life than prazosin
a1-adrengergic blockers in BPH side effects
usually mild
fall in blood pressure due to vasodilatation
postural hypotension - dizziness, syncope
tiredness
headache
ejaculatory dysfunction (tamsulosin)
5a-reductase nhibtors most effective in men wth
men with larger prostate reduce prostate volume reduce rate of disease progression improve symptoms and urine flow decrease incidence of acute urinary retention and requirement for prostate surgery
dutasteride
type 1 and type 2
5a-reductase inhibitor
more effective when combined wth alpha blocker (eg. tamsulosin)
prostate volume reduces after 1 month
sexual adverse effects of 5a-reductase inhibits
erectile dysfunction
ejaculatory disorders
reduced libido
gynaecomastia
sexual dysfunction with 5a-reductase inhibitors is more common when
used in combination with tamsulosin
when used as a mono therapy most side effects resolve spontaneously with ongoing therapy by 2 years but she effects more likely to be ongoing when used in combination with tamsulosin
finasteride
type 2 5a-reductase inhibitor
similar side effect profile as dutasteride
androgens and prostate cancer
growth and development of normal prostate and prostate cancer is androgen dependant
anti-androgen therapy induces apoptosis and reduced cell proliferation
androgen indépendant growth
inevitable n advanced prostate cancer disease
tumour recurrence and progression
called castrate resistant prostate cancer
androgen receptor antagonists
hormonal therapy used for prostate cancer
flutamide, bicalutamide, nilutamide